T 0500/91 (Alpha-interferon II/BIOGEN) of 21.10.1992

European Case Law Identifier: ECLI:EP:BA:1992:T050091.19921021
Date of decision: 21 October 1992
Case number: T 0500/91
Application number: 81300050.2
IPC class: C12N 15/00
Language of proceedings: EN
Distribution: B
Download and more information:
Decision text in EN (PDF, 1 MB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: DNA sequences, recombinant DNA molecules and processes for producing human interferon-alpha like polypeptides
Applicant name: Biogen N.V.
Opponent name: 01) F. Hoffmann-La-Roche & Co.
02) The Upjohn Company
03) Boehringer Ingelheim Zentrale GmbH
04) Bender & Co Ges mbH
05) Cetus Corporation/Triton Biosciences Inc.
06) Hoechst Aktiengesellschaft, Frankfurt
07) Boehringer Mannheim GmbH
09) Boehringer Ingelheim Pharma Ges mbH
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 112(1)
Keywords: Inventive step (yes) - No realistic expectation of success - Activities to be expected from the notional person skilled in the art
Assessment of evidence not a question of law
Catchwords:

-

Cited decisions:
T 0005/81
T 0141/87
T 0301/87
T 0060/89
T 0877/90
Citing decisions:
T 0455/91
T 0886/91
T 0223/92
T 0296/93
T 0412/93
T 0441/93
T 0480/93
T 0207/94
T 0387/94
T 0530/95
T 0639/95
T 0475/96
T 0479/97
T 0338/00
T 1253/04
T 1380/05
T 0178/16

20 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: I Patentability

General Case Law